ArticleIJID regions2026
Practical insights from implementing a national programme for monitoring appropriateness of antimicrobial prescribing in the South-East Asia Region: experience from the CAPTURA project in Bangladesh, Bhutan, and Nepal.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Surveillance of antimicrobial prescribing quality is a core element of national antimicrobial resistance containment strategies. The National Antimicrobial Prescribing Survey (NAPS) programme was implemented in Bangladesh, Bhutan, and Nepal under the Fleming Fund-supported Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia project to strengthen national surveillance and stewardship capacity. The programme comprises setting-specific modules using standardized indicators including documentation quality, guideline concordance, and appropriateness. Methods: Between September 2024 and September 2025, Hospital NAPS point-prevalence audits were conducted in Bangladesh and Nepal, and Surgical NAPS was piloted in Bhutan. Audits were conducted in two phases to enable local interventions between rounds, incorporating stakeholder engagement, structured auditor training, and central quality assurance. Results: Ten hospitals completed audits encompassing 1299 patients (Hospital NAPS), 236 procedures (Surgical NAPS), and 2308 prescriptions. The programme produced baseline prescribing appropriateness data for the first time to inform stewardship priorities across district to tertiary settings. Key enablers included national engagement and establishment of antimicrobial stewardship committees; barriers included incomplete documentation, infrastructure limitations, and coordination challenges. Conclusion: The NAPS programme demonstrated feasibility across diverse health system contexts in three South-East Asia Region countries. Sustained leadership, routine practice integration, local ownership, and committed cross-institutional collaboration are critical for long-term stewardship impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.